Nanosonics Limited (ASX:NAN)

Market Cap	1.36B
Revenue (ttm)	198.63M
Net Income (ttm)	20.68M
Shares Out	303.63M
EPS (ttm)	0.07
PE Ratio	66.97
Forward PE	70.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	710,735
Average Volume	755,362
Open	4.570
Previous Close	4.510
Day's Range	4.420 - 4.570
52-Week Range	2.880 - 5.180
Beta	1.75
RSI	63.45
Earnings Date	Aug 22, 2025

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 a device with an enhanced design and new functionality including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro na...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 470
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In 2025, Nanosonics's revenue was 198.63 million, an increase of 16.83% compared to the previous year's 170.01 million. Earnings were 20.68 million, an increase of 59.39%.